| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |